SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-15
👔
Tenaya Therapeutics, Inc.
@TNYA_InsiderForm 4 Filing: Hyllengren Eric J Acquires (Grant) shares of $TNYA
STOCK AWARD / GRANT
⚡ MATERIALITY: 2/10
corporate issuer
Tenaya Therapeutics, Inc.
Ticker: $TNYA
Transaction Value
N/A (Non-Open-Market)
Price/Share: $0.00 (Non-Open-Market)
transaction date
2026-07-13
Shares: 1,650,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hyllengren Eric J, holds the title of Chief Financial Officer at Tenaya Therapeutics, Inc..
On 2026-07-13, the insider transacted 1,650,000 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Executive Summary Summary
Hyllengren Eric J (Chief Financial Officer) was granted $0 of $TNYA
Post-Transaction Position: 1,650,000 shares
SEC Accession No: 0001193125-26-303681 (CIK: 1966926)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.